Livzon Pharma to Hold 2026 Second EGM; Board Seeks Approval for Q3 Dividend and Three-Year Shareholder Return Plan

Bulletin Express
10/23

Livzon Pharmaceutical Group Inc. (LIVZON PHARMA) has issued a notice convening its 2026 Second Extraordinary General Meeting (EGM) for 14:00 on Thursday, 12 November 2026, at the company’s headquarters in Zhuhai, Guangdong Province.

Key matters up for shareholder vote:

1. Board composition • Appointment of Ms Zhu Linlin as a non-executive director. 2. Profit distribution • Ratification of the Profit Distribution Plan for the third quarter of 2026, which includes a cash dividend (the “Quarterly Dividend”) covering the first three quarters of the year. • Record dates: – A-shareholders – end-of-trading on Tuesday, 24 November 2026 (Shenzhen register). – H-shareholders – close of business on Thursday, 26 November 2026 (Hong Kong register). • Currency: Renminbi for A shares; Hong Kong dollars for H shares, converted at the RMB/HKD central parity rate announced on 12 November 2026.

3. Capital return policy • Endorsement of the Shareholder Return Plan for 2026-2028, setting the framework for dividend and repurchase activities over the next three years.

Voting logistics:

• Shareholders registered by Friday, 6 November 2026 are eligible to attend and vote; all resolutions will be decided by poll. • Proxy submissions must reach the company’s Secretariat (A-shares) or Tricor Investor Services (H-shares) at least 24 hours before the meeting.

Tax treatment of the proposed dividend:

• Overseas individual H-shareholders: 20% individual income tax will be withheld and paid by the company. • Non-resident enterprise H-shareholders: 10% corporate income tax will be withheld; eligible shareholders may subsequently apply for treaty-based refunds. • Mainland investors via Southbound Trading Link: – Individuals: 20% individual income tax withheld. – Enterprises: no withholding; tax to be self-declared.

The EGM is expected to last one hour. Shareholders and proxies attending in person will bear their own travel and accommodation expenses.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10